Profusa Inc

PFSA$27.48+506.62%

Profusa (PFSA) is experiencing extreme volatility today, August 18, 2026, primarily driven by two core factors: a recent reverse stock split and market skepticism surrounding a new acquisition plan.

Firstly, a 1-for-4 reverse stock split became effective on August 17, 2026, drastically reducing the outstanding share count from approximately 2.42 million to about 606,000. This created an exceptionally thin share structure, amplifying price movements significantly. Such post-split mechanics are known to induce massive percentage swings, making PFSA a high-momentum, "battleground" stock for traders. Earlier, on July 7, 2026, the company had also executed a 1-for-25 reverse split.

Secondly, Profusa announced signing a non-binding term sheet to acquire a privately held, commercial-stage diagnostics and toxicology testing company. Despite the target business generating revenue, the market reacted negatively, causing the stock to drop by approximately 18%. Traders are concerned about potential dilution, the need for further financing, and integration risks, especially given Profusa's weak financial position (reporting a Q1 2026 net loss of approximately -$3.46M and only $375,000 cash on hand). These financial vulnerabilities make any acquisition a high-risk proposition in the market's eyes.

The reference news about HRT Financial LP selling shares for $1,234, occurring between August 5-7, 2026, is a minor insider transaction at pre-split prices and is not a significant driver of today's substantial volatility.

Freecast Inc

CAST$2.1+144.24%

FreeCast Ord Shs (Proposed) (CAST) experienced significant volatility today primarily due to the company's announcement of acquiring and planning to relaunch the Investor News Channel as a 24/7 global Free Ad-Supported Streaming Television (FAST) network by November 2026. This news, released on August 18, 2026, served as a fresh catalyst for a stock already known for its speculative nature and high price swings.

CAST's underlying fundamentals are notably weak, characterized by persistent significant losses, minimal revenue, negative equity, and a tight liquidity profile, leading to ongoing "going concern risks" and a reliance on external capital. The stock has a history of being a "volatility magnet," with past surges and sharp pullbacks often driven by sentiment rather than solid financial performance.

Despite the reference news title highlighting "Earnings Forecast: Future EPS & Revenue Growth Estimates" which projects continued negative but improving EPS, the current positive market reaction to today's news is likely a speculative play on potential future revenue streams from the relaunched channel and other recent partnerships, such as with Starlink and DIRECTV. Elevated short interest, which has recently increased by over 60%, can further amplify price movements as traders react aggressively to new information, leading to the observed substantial fluctuations.

IP Strategy Holdings Inc

IPST$15.76+113.26%

IP Strategy Holdings, Inc. (IPST) is experiencing significant volatility today, August 18, 2026, primarily due to the disclosure of delayed Q2 2026 earnings and disappointing preliminary financial results. The company filed a Form 12b-25 with the SEC, notifying a delay in its quarterly 10-Q report. Concurrently, IPST announced an expected net loss for the second quarter of $13.8 million to $17.8 million, a substantial increase from the $7.3 million loss reported in the same period last year. Net revenue is also projected to decline, from $1.3 million to approximately $0.39 million to $0.5 million.

These widening losses are largely attributable to a significant decline in the fair value of intangible digital assets, specifically the $DATA token, and realized losses from digital asset sales. This news follows a massive speculative rally on Monday, August 17th, when IPST shares surged over 277% on high trading volume, driven by investor optimism around its digital asset strategy and potential short-squeeze mechanics, as the company has recently pivoted from a distillery to a digital asset treasury and validator operator focused on programmable intellectual property. Today's fluctuations, therefore, represent a sharp market reaction and a cooling off from that speculative surge, prompted by the negative financial update and regulatory filing delay.

Xos Inc

XOS$4.44+112.44%

Xos, Inc. (NASDAQ: XOS) experienced a significant surge in its stock price today, primarily driven by the announcement of its first contract with the U.S. Air Force. The company secured a prototype Other Transaction Agreement (OTA) to develop and deliver a deployable mobile charging solution for electrified support equipment and vehicles. This marks Xos's strategic entry into the lucrative defense market, which is projected to grow substantially, reaching $19.87 billion by 2033.

This contract news has acted as a powerful catalyst, overshadowing recent Q2 2026 earnings that missed analyst expectations for both EPS and revenue. While the financial results were mixed, with the company achieving its second consecutive quarter of positive gross margins due to a focus on higher-margin products like the Xos Hub, the market's reaction clearly prioritized the long-term growth potential and validation offered by the Air Force contract. The stock saw extraordinary trading volume, soaring over 188% in premarket trading. Although Xos has a measurable short interest, the immediate and drastic upward fluctuation is directly attributable to this major contract win and the expansion into a new, high-potential sector, rather than a short squeeze.

Super League Enterprise Inc

SLE$5.5+82.12%

SLE's significant stock surge today is primarily driven by a transformative strategic investment and corporate restructuring, rather than solely its recently reported Q2 2026 financial results. While Super League Enterprise's Q2 earnings, released on August 14, 2026, showed encouraging operational improvements—including a 16% sequential increase in net revenue, a gross margin expansion to 41% from 36%, and a 20% year-over-year improvement in adjusted EBITDA loss to -$1.7 million—these factors contributed to the "tightened path to profitability" narrative but were likely not the sole catalyst for a dramatic daily jump. The company also reiterated its target for adjusted EBITDA profitability by Q4 2026, reinforcing a positive outlook on its core gaming media business.

The core reason for today's sharp upward movement is the announcement, also on August 18, 2026, of a definitive agreement with Metaplanet, Inc.. Under this agreement, Metaplanet will invest 2,100 Bitcoin, valued at approximately $132.1 million, along with $2.5 million in cash into Super League. In exchange, Metaplanet will receive a controlling stake, fundamentally transforming Super League into "Superplanet, Inc.," a Nasdaq-listed Bitcoin treasury platform that will become a consolidated subsidiary of Metaplanet. This massive injection of capital, coupled with the shift to a Bitcoin treasury model and the association with a significant crypto player, represents a far more impactful event than the Q2 earnings alone, triggering substantial investor interest and volume, leading to the reported jump of over 94%. The stock is experiencing extreme volatility and high trading volume, typical for such a major corporate re-alignment and capital infusion.

Amylyx Pharmaceuticals Inc

AMLX$35.11+63.84%

Amylyx Pharmaceuticals (NASDAQ:AMLX) experienced a substantial surge, hitting a new 12-month high on August 18, 2026, primarily driven by overwhelmingly positive topline results from its Phase 3 LUCIDITY clinical trial for avexitide in post-bariatric hypoglycemia (PBH). The trial successfully met its FDA-agreed primary endpoint, demonstrating a statistically significant 55% reduction in combined Level 2 and Level 3 hypoglycemic events compared to placebo. All secondary endpoints were also achieved, and avexitide exhibited a favorable safety profile.

This breakthrough is a critical catalyst as there are currently no FDA-approved therapies for PBH, positioning avexitide as a potential first-in-class treatment. The company plans to submit a New Drug Application (NDA) to the FDA by the end of 2026, with a prospective commercial launch in 2027, if approved. Following the trial success, multiple analysts upgraded their outlooks; for instance, Mizuho raised its price target to $30 from $24, and HC Wainwright significantly increased its target to $55 from $34, citing a 100% probability of success for the drug. This combination of strong clinical data and subsequent analyst confidence ignited the significant upward stock movement.

Greenlane Holdings Inc

GNLN$3.05+51.74%

Greenlane Holdings, Inc. (GNLN) has recently experienced significant stock price volatility, primarily driven by its dismal Second Quarter 2026 financial results, which were reported on August 14, 2026. The company disclosed a severe year-over-year revenue plunge of approximately 90%, with net revenue plummeting to just $82,000. Concurrently, Greenlane's net loss attributable to shareholders widened substantially to $(24.8) million from $(3.2) million in the prior year period.

A key factor contributing to the increased losses was a significant non-cash change in the fair value of its digital assets, amounting to a negative $(19.1) million, along with an investment impairment charge of approximately $(1.8) million. This highlights challenges within its newer Berachain-focused digital asset treasury strategy, despite efforts to reduce operating expenses by approximately 37% sequentially. Furthermore, concerns about the company's liquidity, with cash and cash equivalents declining to $6.1 million from $32.5 million, and its statement that it would fall below Nasdaq's $5.0 million market value threshold without a stayed rule change, add to investor apprehension regarding its continued listing compliance. These poor financial indicators are the direct cause of any sharp negative market reaction.

PS International Group Ltd

PSIG$1.59+47.22%

PSIG's significant volatility today stems directly from the Nasdaq Listing Qualifications deficiency notice received by PS International Group on August 12, 2026, and publicly disclosed on August 14, 2026. The core issue is the company's failure to maintain a minimum Market Value of Listed Securities (MVLS) of US$35 million over a 30-day monitoring period, from June 30 to August 11, 2026. Furthermore, PSIG also failed to meet alternative Nasdaq continued listing standards, including minimum stockholders' equity of US$2.5 million and minimum annual net income of US$500,000.

Nasdaq has granted PSIG a 180-calendar-day period, until February 8, 2027, to regain compliance by ensuring its MVLS closes at or above US$35 million for at least ten consecutive trading days. While the notice does not result in an immediate suspension or delisting, and shares continue to trade normally, the substantial gap between its current market capitalization (around US$16-19 million) and the required US$35 million threshold presents a significant challenge and delisting risk. This regulatory pressure, combined with the company's underlying weak fundamentals such as declining revenue, unprofitability, and negative cash flows, has fueled investor uncertainty and caused the observed sharp price movements.

E-Home Household Service Holdings Ltd

EJH$2.06+42.07%

EJH (E-Home Household Service Holdings Limited) stock is experiencing significant volatility today, August 18, 2026, primarily driven by highly positive market sentiment surrounding its newly introduced "eHome Property Management System". This platform, an already-deployed system that EJH acquired and rebranded, is positioned as a community access and data gateway integrated with its core home services. The company aims to monetize this system through sales and leasing to property managers, targeting scalable, recurring revenue streams with potentially higher margins.

The stock has seen intraday surges as high as $3.83 before pulling back, exhibiting the characteristics of a low-priced, small-cap momentum play where news flow and speculative trading heavily influence price movements. EJH's fundamentals show roughly $49.4 million in fiscal year 2025 revenue and a notably low price-to-sales ratio around 0.11. The balance sheet appears strong with approximately $173 million in cash and modest liabilities, providing capital for such new ventures.

While the company has undergone multiple reverse stock splits in 2025 and 2026 to maintain Nasdaq listing compliance, contributing to its historical volatility, today's sharp upward movement is directly attributable to the market's enthusiastic reaction to the new eHome platform's potential for recurring revenue, attracting active traders and creating a "day trader's playground". Short interest, while showing a recent increase, does not appear to be the primary catalyst for this magnitude of intraday swing; rather, the news-driven momentum is paramount.

China SXT Pharmaceuticals Inc

SXTC$5.13+36.80%

SXTC's recent dramatic volatility, characterized by its stock rocketing from sub-$0.10 to the $3-$5 range and even spiking above $6, is primarily driven by a confluence of a reverse stock split, an ultra-low float, and a significant short interest spike, leading to classic short squeeze dynamics.

The company, China SXT Pharmaceuticals Inc., implemented a massive reverse stock split, including a 1-for-80 split effective August 10, 2026, and a previous 1-for-150 split, largely aimed at regaining Nasdaq minimum bid price compliance. These reverse splits drastically reduced the number of publicly tradable shares, creating an "ultra-low float" environment.

Compounding this, short interest in SXTC surged by over 20,000% as of July 31, 2026, reaching 4.61 million shares, representing approximately 12.57% of the public float. This substantial increase in bearish bets against a thinly traded stock with a days-to-cover ratio of 0.0 (indicating shorts could cover positions very quickly if forced) created fertile ground for a short squeeze. As the price began to rise, short sellers were compelled to buy back shares to limit losses, further fueling the upward momentum.

While SXTC boasts a strong balance sheet with around $28 million in cash and minimal debt, its core business suffers from weak profitability and negative returns on capital. The market also heavily discounts its book value. This disconnect, combined with the technical factors of low float and high short interest, has transformed SXTC into a "pure price-action and sentiment play," attracting aggressive momentum traders rather than being driven by fundamental performance.